Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Pfizer, Lilly Announce Top-line Results from Tanezumab Phase 3 Study

americanpharmaceuticalreviewFebruary 20, 2019

Tag: tanezumab , CLBP , Pfizer , Lilly

PharmaSources Customer Service